Ace inhibitors mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Action of ACE Inhibitors
Introduction to ACE Inhibitors
Angiotensin-converting enzyme (ACE) inhibitors are a class of medications widely used to manage hypertension, heart failure, and other cardiovascular and renal diseases. They function by inhibiting the activity of the ACE enzyme, which plays a crucial role in the renin-angiotensin-aldosterone system (RAAS) that regulates blood pressure and fluid balance 45.
Inhibition of Angiotensin II Production
The primary mechanism of ACE inhibitors involves the blockade of the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. By reducing the levels of angiotensin II, ACE inhibitors prevent vasoconstriction, thereby lowering blood pressure. This reduction in angiotensin II also decreases the secretion of aldosterone, leading to reduced sodium and water retention, which further helps in lowering blood pressure 456.
Enhancement of Bradykinin Levels
ACE inhibitors also prevent the breakdown of bradykinin, a peptide that promotes vasodilation. Increased levels of bradykinin contribute to the vasodilatory effects of ACE inhibitors, enhancing their ability to lower blood pressure. This dual action on angiotensin II and bradykinin is crucial for the therapeutic effects of ACE inhibitors 456.
Non-Competitive Inhibition by Peptides
Research has shown that certain peptides can inhibit ACE activity through non-competitive mechanisms. For instance, peptides derived from hazelnut and yeast have been found to bind to ACE at sites other than the active site, altering the enzyme's conformation and reducing its activity. These peptides interact with the enzyme through various molecular interactions, including hydrogen bonding and cation-pi interactions, which contribute to their inhibitory effects 178.
Molecular Dynamics and Structural Insights
Advanced studies using molecular dynamics simulations have provided deeper insights into the conformational changes induced by ACE inhibitors. For example, the binding of specific dipeptides like Ile-Tyr (IY) can cause significant structural shifts in the ACE enzyme, stabilizing certain regions and maintaining the enzyme in a closed state, which is less active. These structural changes are crucial for the high inhibitory activity of these peptides .
Cardioprotective and Antifibrotic Effects
Beyond blood pressure reduction, ACE inhibitors have been shown to exert cardioprotective effects by reducing cardiac fibrosis and cell proliferation. This is partly due to the inhibition of the hydrolysis of N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP), a peptide that has antifibrotic properties. By preventing the breakdown of Ac-SDKP, ACE inhibitors help reduce collagen deposition and inflammation in the heart, which is beneficial in conditions like left ventricular hypertrophy and heart failure .
Conclusion
ACE inhibitors are effective antihypertensive agents that work by inhibiting the conversion of angiotensin I to angiotensin II and preventing the breakdown of bradykinin. Their ability to induce structural changes in the ACE enzyme and their cardioprotective effects make them valuable in the treatment of various cardiovascular conditions. Understanding the detailed mechanisms of action of ACE inhibitors, including their interactions with inhibitory peptides and their effects on molecular dynamics, can aid in the development of more targeted and effective therapies for hypertension and related diseases.
Sources and full results
Most relevant research papers on this topic